Industry / Pharmaceuticals: Major
Latest filings
DEF 14C
PPCB
Propanc Biopharma
9 Jun 22
Information statement
12:35pm
PRE 14C
PPCB
Propanc Biopharma
27 May 22
Preliminary information
2:15pm
8-K
PPCB
Propanc Biopharma
18 May 22
Entry into a Material Definitive Agreement
12:29pm
10-Q
2022 Q3
PPCB
Propanc Biopharma
16 May 22
Quarterly report
11:24am
10-Q
2022 Q3
PCYN
Procyon
11 May 22
Quarterly report
4:57pm
8-K
PPCB
Propanc Biopharma
18 Apr 22
Entry into a Material Definitive Agreement
2:19pm
8-K
PPCB
Propanc Biopharma
1 Apr 22
Entry into a Material Definitive Agreement
2:59pm
8-K
PPCB
Propanc Biopharma
10 Mar 22
Entry into a Material Definitive Agreement
1:31pm
424B3
PPCB
Propanc Biopharma
22 Feb 22
Prospectus supplement
11:53am
10-Q
2022 Q2
PPCB
Propanc Biopharma
14 Feb 22
Quarterly report
1:14pm
IPOs and registrations IPOs & registrations
News
Roche-AC Immune's Crenezumab Fails To Show Benefit In Sub-Set Of Alzheimer's Patients
ACIU
RHHBF
16 Jun 22
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
BNTX
MRK
RHHBF
6 Jun 22
Seagen Posts Encouraging Data From Tucatinib Combo Trial In Colorectal Cancer
MRK
RHHBF
SGEN
23 May 22
Genentech's Tiragolumab/Tecentriq Fails On Progression Free Survival In PD-L1-High Metastatic Lung Cancer
RHHBF
RHHVF
11 May 22
Roche Releases More Evrysdi Data For Very Young Infants With SMA
RHHBF
RHHVF
29 Apr 22
Roche's CEO Warns Russia-Ukraine War Causing Problems For Multiple Sclerosis Trials
RHHBF
RHHVF
25 Apr 22
COVID-19 Tests Boost Roche's Q1 Sales, Reaffirms FY22 Outlook
RHHBF
RHHVF
25 Apr 22
EMA' Advisory Committee Recommends Approval For Roche's Two Cancer Drugs
RHHBF
RHHVF
22 Apr 22
FDA Warns Against Relying On Screening Tests For Prenatal Diagnosis
A
ILMN
MYGN
20 Apr 22
Read Why Pliant Therapeutics Shares Are Soaring Today
PLRX
RHHBF
RHHVF
13 Apr 22
Press releases
Propanc Biopharma Announces No Immediate Plans for Reverse Stock Split
PPCB
24 Jun 22
Propanc Biopharma's CSO Hails Dostarlimab's Impressive Results Whilst Acknowledging More Work to Be Done in the Fight Against Cancer
PPCB
22 Jun 22
Propanc Biopharma Undertaking PRP Manufacturing & Development for Human Use
PPCB
18 May 22
Propanc Biopharma's Management Explains Why They Believe Cancer Patients Are Likely to Respond to PRP Treatment
PPCB
13 Apr 22
Transcripts
MKGAF
2022 Q1
Earnings call transcript
13 May 22
MKGAF
2021 Q2
Earnings call transcript
7 Aug 21
LQDA
2020 Q4
Earnings call transcript
23 Mar 21
MKGAF
2020 Q3
Earnings call transcript
13 Nov 20
LQDA
2020 Q3
Earnings call transcript
9 Nov 20
LQDA
2020 Q2
Earnings call transcript
10 Aug 20
AMAG
2020 Q2
Earnings call transcript
9 Aug 20
LQDA
2020 Q1
Earnings call transcript
11 May 20
AMAG
2020 Q1
Earnings call transcript
11 May 20
LQDA
2019 Q4
Earnings call transcript
11 Mar 20
Patents
Utility
Multispecific Agents for Treatment of Cancer
FTSV
16 Jun 22
Utility
Modulators of Complement Activity
RARX
26 May 22
Design
Packaging
MKGAF
17 May 22
Design
Label
MKGAF
10 May 22
Utility
Neurological Disease Treatment with Zilucoplan
RARX
5 May 22
Utility
Humanized Antibodies Against C-kit
FTSV
28 Apr 22
Utility
Cyclic Polypeptides for PCSK9 Inhibition
RARX
24 Mar 22
Utility
Substituted Pyrazolo[3,4-d]Pyrimidines as Kinase Inhibitors
PRNB
10 Mar 22
Utility
Immunoproteasome Inhibitors
PRNB
10 Mar 22
Design
Packaging
MKGAF
1 Feb 22